Increased COX-2, CB2, and P2X7 in Microglial Cells of MS and ALS Spinal Cord
Author Information
Author(s): Yiangou Yiangos, Paul Facer, Pascal Durrenberger, Iain P Chessell, Alan Naylor, Chas Bountra, Richard R Banati, Praveen Anand
Primary Institution: Imperial College, Hammersmith Hospital, London, UK
Hypothesis
The study investigates the expression of COX-2, CB2, and P2X7 in activated microglial cells/macrophages in the spinal cord of patients with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS).
Conclusion
The study found increased levels of COX-2, CB2, and P2X7 in microglial cells/macrophages in the spinal cords of MS and ALS patients compared to controls.
Supporting Evidence
- COX-2 expression was significantly increased in MS spinal cord compared to controls.
- Greater density of P2X7 and CB2-immunoreactive microglial cells/macrophages was observed in affected regions of MS and ALS.
- Correlation between COX-2 immunostaining and optical density of the COX-2 70-kDa band was found in the MS group.
Takeaway
Researchers looked at brain samples from people with MS and ALS and found that certain proteins related to inflammation were much higher in those samples than in healthy ones.
Methodology
The study used immunocytochemistry and Western blotting on frozen human post-mortem spinal cord specimens from controls, ALS, and MS patients.
Potential Biases
Potential bias may arise from the selection of post-mortem samples and the interpretation of immunohistochemical results.
Limitations
The study is limited by the post-mortem nature of the samples and the potential for variability in the timing of tissue collection.
Participant Demographics
The study included 12 control subjects, 9 ALS patients, and 19 MS patients.
Statistical Information
P-Value
0.0011
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website